Biogen Inc. (LON:0R1B)
195.52
+4.97 (2.61%)
Feb 12, 2026, 4:59 PM GMT
Biogen Revenue
In the year 2025, Biogen had annual revenue of $9.89B USD with 2.22% growth. Biogen had revenue of $2.28B in the quarter ending December 31, 2025, a decrease of -7.14%.
Revenue
$9.89B
Revenue Growth
+2.22%
P/S Ratio
2.80
Revenue / Employee
$1.32M
Employees
7,500
Market Cap
20.57B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.89B | 214.70M | 2.22% |
| Dec 31, 2024 | 9.68B | -159.70M | -1.62% |
| Dec 31, 2023 | 9.84B | -337.80M | -3.32% |
| Dec 31, 2022 | 10.17B | -808.30M | -7.36% |
| Dec 31, 2021 | 10.98B | -2.46B | -18.32% |
| Dec 31, 2020 | 13.44B | -933.30M | -6.49% |
| Dec 31, 2019 | 14.38B | 925.00M | 6.88% |
| Dec 31, 2018 | 13.45B | 1.18B | 9.61% |
| Dec 31, 2017 | 12.27B | 825.10M | 7.21% |
| Dec 31, 2016 | 11.45B | 685.00M | 6.36% |
| Dec 31, 2015 | 10.76B | 1.06B | 10.93% |
| Dec 31, 2014 | 9.70B | 2.77B | 39.97% |
| Dec 31, 2013 | 6.93B | 1.42B | 25.66% |
| Dec 31, 2012 | 5.52B | 467.83M | 9.27% |
| Dec 31, 2011 | 5.05B | 332.21M | 7.04% |
| Dec 31, 2010 | 4.72B | 339.08M | 7.75% |
| Dec 31, 2009 | 4.38B | 279.84M | 6.83% |
| Dec 31, 2008 | 4.10B | 925.89M | 29.19% |
| Dec 31, 2007 | 3.17B | 488.57M | 18.21% |
| Dec 31, 2006 | 2.68B | 260.55M | 10.76% |
| Dec 31, 2005 | 2.42B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Biogen News
- 1 day ago - Biogen Inc (BIIB) Insider Priya Singhal Sells 2,660 Shares - GuruFocus
- 2 days ago - BIIB: Wedbush Raises Price Target to $187 While Maintaining Neutral Rating | BIIB Stock News - GuruFocus
- 2 days ago - Systematic Core Fund Sells 2,530 Shares of Biogen Inc (BIIB) - GuruFocus
- 2 days ago - Nasdaq-100 Index Fund Sells 230 Shares of Biogen Inc (BIIB) - GuruFocus
- 2 days ago - Mid Cap Value Fund Buys 10,934 Shares of Biogen Inc (BIIB) - GuruFocus
- 2 days ago - Analyst JP Morgan Raises Price Target for Biogen (BIIB) to $230 | BIIB Stock News - GuruFocus
- 3 days ago - Biogen (BIIB) Sees Raised Price Target by Canaccord Genuity | BIIB Stock News - GuruFocus
- 3 days ago - Biogen (BIIB) Analyst Rating Update: Citigroup Raises Price Target | BIIB Stock News - GuruFocus